Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide

4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide

4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Structure
4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide structure
CAS No.
506417-09-0
Chemical Name:
4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide
Synonyms
GPR41 agonist-1;4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide
CBNumber:
CB21909164
Molecular Formula:
C24H23N3O4
Molecular Weight:
417.45712
MDL Number:
MOL File:
506417-09-0.mol
MSDS File:
SDS
Last updated:2026-04-22 18:57:36
Request For Quotation

4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Properties

form Solid
color Light yellow to yellow

4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0568618 GPR41 agonist-1 98.04% 506417-09-0 5mg $103 2026-06-04 Buy
ChemScene CS-0568618 GPR41 agonist-1 98.04% 506417-09-0 10mg $179 2026-06-04 Buy
ChemScene CS-0568618 GPR41 agonist-1 98.04% 506417-09-0 25mg $374 2026-06-04 Buy
ChemScene CS-0568618 GPR41 agonist-1 98.04% 506417-09-0 50mg $596 2026-06-04 Buy
ChemScene CS-0568618 GPR41 agonist-1 98.04% 506417-09-0 100mg $1029 2026-06-04 Buy
Product number Packaging Price Buy
CS-0568618 5mg $103 Buy
CS-0568618 10mg $179 Buy
CS-0568618 25mg $374 Buy
CS-0568618 50mg $596 Buy
CS-0568618 100mg $1029 Buy

4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Chemical Properties, Uses, Production

Uses

GPR41 agonist-1 (compound 9) is a potent GPR41 agonist. GPR41 agonist-1 can be used for researching insulin-related disorders[1].

References

[1] James N. Leonard, et al. Gpr41 and modulators thereof for the treatment of insulin-related disorders. WO2006052566A2.

4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Preparation Products And Raw materials

Raw materials

Preparation Products

4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide Suppliers

Global Suppliers ( 8)
Supplier Tel Email Country ProdList Advantage
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
RD International Technology Co., Limited 18024082417 market@ubiochem.com China 9831 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 29874 58
Shanghai Amole Biotechnology Co., Ltd. 13370042665 18916960931 2596183085@qq.com China 17234 58
Guangzhou Ruidi Biotechnology Co., Ltd. 020-82099279 18988941402 sales@ubiochem.com China 9998 58
TargetMol Chemicals Inc. +1-781-999-5354; support@targetmol.com United States 38999 58
Supplier Advantage
Shanghai Yifei Biotechnology Co. , Ltd. 58
RD International Technology Co., Limited 58
TargetMol Chemicals Inc. 58
Shanghai Amole Biotechnology Co., Ltd. 58
Guangzhou Ruidi Biotechnology Co., Ltd. 58
TargetMol Chemicals Inc. 58

View Latest Price from 4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
GPR41 agonist-1 pictures 2026-04-22 GPR41 agonist-1
506417-09-0
 $99.00 98.40% 10g TargetMol Chemicals Inc.

506417-09-0 (4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide) Related Search:

N-(2,5-dichlorophenyl)-4-(furan-2-yl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxamide SCO-267 4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97% TUG 891 N-(4-butylphenyl)-4-fluorobenzenesulfonamide
AMG 837 (calciuM hydrate)

1of2

4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide GPR41 agonist-1 506417-09-0